Bayer and Loxo Oncology to develop and commercialize two therapies that selectively target genetic drivers of cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Bayer and Loxo Oncology to develop and commercialize two therapies that selectively target genetic drivers of cancer
(NASDAQ: LOXO) Delayed: 234.80 --0 (-0%)
Previous Close $234.80    52 Week High $35.00 
Open $5.92    52 Week Low $16.36 
Day High $234.80    P/E N/A 
Day Low $234.80    EPS $0.00 
Volume 1,125,528